Humanwell Healthcare (China) Today

600079 Stock   20.42  0.09  0.44%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Humanwell Healthcare is trading at 20.42 as of the 18th of February 2025, a 0.44 percent decrease since the beginning of the trading day. The stock's open price was 20.51. Humanwell Healthcare has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 1st of March 2023 and ending today, the 18th of February 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
22nd of May 1997
Category
Healthcare
Classification
Health Care
Humanwell Healthcare is entity of China. It is traded as Stock on SHG exchange. The company has 1.63 B outstanding shares. More on Humanwell Healthcare Group

Moving together with Humanwell Stock

  0.66600715 Cultural InvestmentPairCorr
  0.67900921 Danhua Chemical TechPairCorr
  0.63002188 Bus OnlinePairCorr
  0.73000980 Zotye AutomobilePairCorr

Humanwell Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Humanwell Healthcare's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Humanwell Healthcare or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Vice PresidentLie Li
Thematic IdeaHealth Management (View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors)
Humanwell Healthcare's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Humanwell Healthcare's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Humanwell Healthcare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Humanwell Healthcare's financial leverage. It provides some insight into what part of Humanwell Healthcare's total assets is financed by creditors.
Liquidity
Humanwell Healthcare cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Humanwell Healthcare Group has accumulated 6.71 B in total debt. Debt can assist Humanwell Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Humanwell Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Humanwell Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Humanwell to invest in growth at high rates of return. When we think about Humanwell Healthcare's use of debt, we should always consider it together with cash and equity.

Other Cashflows From Financing Activities

(118.08 Million)
Humanwell Healthcare Group (600079) is traded on Shanghai Stock Exchange in China and employs 17,676 people. Humanwell Healthcare is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 33.38 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Humanwell Healthcare's market, we take the total number of its shares issued and multiply it by Humanwell Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Humanwell Healthcare operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 1.63 B outstanding shares. Humanwell Healthcare generates positive cash flow from operations, but has no cash available
Check Humanwell Healthcare Probability Of Bankruptcy
Ownership Allocation
Humanwell Healthcare Group has a total of 1.63 Billion outstanding shares. Humanwell Healthcare secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Humanwell Ownership Details

Humanwell Healthcare Risk Profiles

Although Humanwell Healthcare's alpha and beta are two of the key measurements used to evaluate Humanwell Healthcare's performance over the market, the standard measures of volatility play an important role as well.

Humanwell Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Humanwell Healthcare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run ETF Categories Now

   

ETF Categories

List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
All  Next Launch Module

Humanwell Healthcare Corporate Executives

Elected by the shareholders, the Humanwell Healthcare's board of directors comprises two types of representatives: Humanwell Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Humanwell. The board's role is to monitor Humanwell Healthcare's management team and ensure that shareholders' interests are well served. Humanwell Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Humanwell Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.

Other Information on Investing in Humanwell Stock

Humanwell Healthcare financial ratios help investors to determine whether Humanwell Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humanwell with respect to the benefits of owning Humanwell Healthcare security.